RecruitingNCT02486562
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
Sponsor
Accelerated Cure Project for Multiple Sclerosis
Enrollment
20,000 participants
Start Date
Nov 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.
Eligibility
Inclusion Criteria1
- years of age or older at the time of informed consent or under 21 with parental consent and participant assent.
Exclusion Criteria1
- Unwilling or unable to provide informed consent.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02486562
Related Trials
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT048734921 location
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
NCT074776392 locations
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NCT067824641 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
NCT072253611 location